ReviewFrontiers in pediatrics2026
Plastic bronchitis: a narrative review of the classification methods and pathogenesis.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endobronchial abnormalities and bronchoalveolar lavage findings in children with severe pneumonia andFrontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plastic bronchitis (PB) is a rare but potentially life-threatening disorder characterized by bronchial cast formation and airway obstruction. This narrative review synthesizes the evolution of PB classification and, in particular, integrates emerging evidence supporting a subtype-oriented framework-lymphatic vs. eosinophilic PB-based on distinct etiologies and pathophysiological mechanisms. We searched PubMed, Embase, Cochrane Library, and Web of Science for relevant clinical and experimental studies and reviews published up to February 2026, focusing on classification, mechanisms, diagnostic approaches, and therapies. We summarize key mechanistic pathways and the practical implications of advanced lymphatic imaging (e.g., DCMRL, CT lymphangiography) and immunopathology for improving subtype-specific diagnosis, guiding mechanism-based treatment beyond supportive care, and interpreting therapeutic responses. Finally, we highlight major knowledge gaps and propose priorities for future translational and clinical research to refine diagnostic criteria and develop precision therapies for PB subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.